Small non-coding RNAs govern mammary gland tumorigenesis

Journal of Mammary Gland Biology and Neoplasia

Volumn 17, Issue 1, 2012, Pages 59-64

  Yu, Zuoren ^a,b,c   Pestell, Richard G ^b,c  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Breast cancer; Cell cycle; miRNA; Non coding RNA; Tumorigenesis

Indexed keywords

FLUOROURACIL; MICRORNA; MICRORNA 145; MICRORNA 26A; MICRORNA 34A; PIWI INTERACTING RNA; SMALL INTERFERING RNA; SMALL NUCLEOLAR RNA; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG;

APOPTOSIS; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GENE THERAPY; CANCER GROWTH; CANCER RECURRENCE; CANCER STEM CELL; CELL CYCLE REGULATION; CELL PROLIFERATION; EXPRESSION VECTOR; GENE EXPRESSION REGULATION; GENE FUNCTION; HUMAN; LIVER CANCER; LUNG NON SMALL CELL CANCER; NONHUMAN; PROGNOSIS; REGULATORY MECHANISM; REVIEW; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; MAMMARY GLANDS, HUMAN; RNA, SMALL UNTRANSLATED;

EID: 84858698526     PISSN: 10833021     EISSN: 15737039     Source Type: Journal    
DOI: 10.1007/s10911-012-9246-4     Document Type: Review

References (66)

1. Ambros V. The functions of animal microRNAs. Nature. 2004;431 (7006):350-5. (Pubitemid 39265675)
2. Cullen BR. Transcription and processing of human microRNA precursors. Mol Cell. 2004;16(6):861-5. (Pubitemid 40018397)
3. Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, Barad O, et al. Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet. 2005;37(7):766-70. (Pubitemid 41754896)
4. Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, Thomson AM, et al. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell. 2006;126(6):1203-17. (Pubitemid 44380294)
5. Cui Q, Yu Z, Purisima EO, Wang E. Principles of microRNA regulation of a human cellular signaling network. Mol Syst Biol. 2006;2:46.
6. Tili E, Michaille JJ, Gandhi V, Plunkett W, Sampath D, Calin GA. miRNAs and their potential for use against cancer and other diseases. Future Oncol. 2007;3(5):521-37. (Pubitemid 47595862)
7. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nature Reviews. 2006;6(11):857-66. (Pubitemid 44629897)
8. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004;101(9):2999-3004. (Pubitemid 38327724)
9. Zhang B, Pan X, Cobb GP, Anderson TA. microRNAs as oncogenes and tumor suppressors. Dev Biol. 2007;302(1):1-12. (Pubitemid 46096921)
10. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nature Reviews. 2006;6(4):259-69.
11. Cummins JM, Velculescu VE. Implications of micro-RNA profiling for cancer diagnosis. Oncogene. 2006;25(46):6220-7. (Pubitemid 44527853)
12. Hahn WC, Weinberg RA. Rules for making human tumor cells. N Engl J Med. 2002;347(20):1593-603. (Pubitemid 35315841)
13. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281-97.
14. Lin SL, Miller JD, Ying SY. Intronic microRNA (miRNA). J Biomed Biotechnol. 2006;2006(4):26818.
15. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005;65(16):7065-70. (Pubitemid 41161233)
16. Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A, et al. microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci U S A. 2006;103 (24):9136-41. (Pubitemid 43902545)
17. Wang F, Zheng Z, Guo J, Ding X. Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor. Gynecol Oncol. 2010;119(3):586-93.
18. Yu Z, Wang C, Wang M, Li Z, Casimiro MC, Liu M, et al. A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J Cell Biol. 2008;182(3):509-17.
19. Yu Z, Willmarth NE, Zhou J, Katiyar S, Wang M, Liu Y, et al. microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling. Proc Natl Acad Sci U S A. 2010;107(18):8231-6.
20. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435(7043):834-8. (Pubitemid 40839735)
21. Adams BD, Guttilla IK, White BA. Involvement of microRNAs in breast cancer. Semin Reprod Med. 2008;26(6):522-36.
22. Le Quesne J, Caldas C. Micro-RNAs and breast cancer. Mol Oncol. 2010;4(3):230-41.
23. Fu M, Wang C, Li Z, Sakamaki T, Pestell RG. Minireview: Cyclin D1: normal and abnormal functions. Endocrinology. 2004;145 (12):5439-47.
24. Jiang W, Kahn SM, Tomita N, Zhang YJ, Lu SH, Weinstein IB. Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res. 1992;52(10):2980-3.
25. Lee RJ, Albanese C, Fu M, D'Amico M, Lin B, Watanabe G, et al. Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway. Mol Cell Biol. 2000;20(2):672-83. (Pubitemid 30023109)
26. Deshpande A, Pastore A, Deshpande AJ, Zimmermann Y, Hutter G, Weinkauf M, et al. 3′UTR mediated regulation of the cyclin D1 proto-oncogene. Cell Cycle. 2009;8(21):3584-92.
27. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004;64(11):3753-6. (Pubitemid 38697282)
28. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, et al.MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA. 2008;299 (4):425-36. (Pubitemid 351185951)
29. Yang N, Kaur S, Volinia S, Greshock J, Lassus H, Hasegawa K, et al. MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Res. 2008;68(24):10307-14.
30. Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, et al. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell. 2007;131(6):1109-23. (Pubitemid 350235025)
31. Schultz J, Lorenz P, Gross G, Ibrahim S, Kunz M. MicroRNA let- 7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. Cell Res. 2008;18(5):549-57. (Pubitemid 351630945)
32. Wang C, Li Z, Lu Y, Du R, Katiyar S, Yang J, et al. Cyclin D1 repression of nuclear respiratory factor 1 integrates nuclear DNA synthesis and mitochondrial function. Proc Natl Acad Sci U S A. 2006;103(31):11567-72. (Pubitemid 44182492)
33. Sakamaki T, CasimiroMC, Ju X, Quong AA, Katiyar S, LiuM, et al. Cyclin D1 determines mitochondrial function in vivo.Mol Cell Biol. 2006;26(14):5449-69. (Pubitemid 44036212)
34. Li Z, Jiao X, Wang C, Ju X, Lu Y, Yuan L, et al. Cyclin D1 induction of cellular migration requires p27(KIP1). Cancer Res. 2006;66(20):9986-94. (Pubitemid 44672051)
35. Casimiro M, Crosariol M, Loro E, Ertel A, Yu Z, Dampier W, et al. ChIP-Sequencing of cyclin D1 in mouse reveals a transcriptional role in chromosomal instability. J Clin Invest. 2012;Feb 6.
36. Miller TE, Ghoshal K, Ramaswamy B, Roy S, Datta J, Shapiro CL, et al. MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. J Biol Chem. 2008;283 (44):29897-903.
37. Kim YK, Yu J, Han TS, Park SY, Namkoong B, Kim DH, et al. Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res. 2009;37(5):1672-81.
38. Stinson S, Lackner MR, Adai AT, Yu N, Kim HJ, O'Brien C, et al. miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer. Sci Signal. 2011;4(186):pt5.
39. Zhao JJ, Lin J, Yang H, Kong W, He L, Ma X, et al. MicroRNA- 221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer. J Biol Chem. 2008;283(45):31079-86.
40. Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY. miR-21-mediated tumor growth. Oncogene. 2007;26(19):2799-803. (Pubitemid 46663837)
41. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem. 2008;283(2):1026-33.
42. Bourguignon LY, Spevak CC,Wong G, XiaW, Gilad E. Hyaluronan- CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells. J Biol Chem. 2009;284(39):26533- 46.
43. Zhu S, Si ML, Wu H, Mo YY. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem. 2007;282 (19):14328-36. (Pubitemid 47100416)
44. Wang P, Zou F, Zhang X, Li H, Dulak A, Tomko Jr RJ, et al. microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells. Cancer Res. 2009;69(20):8157-65.
45. Jin Y. 3,3′-Diindolylmethane inhibits breast cancer cell growth via miR-21-mediated Cdc25A degradation. Mol Cell Biochem. 2011;358(1-2):345-54.
46. Scott GK, Mattie MD, Berger CE, Benz SC, Benz CC. Rapid alteration of microRNA levels by histone deacetylase inhibition. Cancer Res. 2006;66(3):1277-81. (Pubitemid 43259904)
47. Mertens-Talcott SU, Chintharlapalli S, Li X, Safe S. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res. 2007;67(22):11001-11. (Pubitemid 350145930)
48. Booher RN, Holman PS, Fattaey A. Human Myt1 is a cell cycleregulated kinase that inhibits Cdc2 but not Cdk2 activity. J Biol Chem. 1997;272(35):22300-6. (Pubitemid 27382865)
49. Gupta PB, Chaffer CL,Weinberg RA. Cancer stem cells: mirage or reality? Nat Med. 2009;15(9):1010-2.
50. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003;100(7):3983-8. (Pubitemid 36418143)
51. Shimono Y, Zabala M, Cho RW, Lobo N, Dalerba P, Qian D, et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell. 2009;138(3):592-603.
52. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008;10(5):593-601. (Pubitemid 351627379)
53. Yu F, Jiao Y, Zhu Y, Wang Y, Zhu J, Cui X, et al. MiR-34c downregulation via DNA methylation promotes self-renewal and epithelial-mesenchymal transition in breast tumor-initiating cells. J Biol Chem. 2012;287(1):465-73.
54. Zhu Y, Yu F, Jiao Y, Feng J, Tang W, Yao H, et al. Reduced miR- 128 in breast tumor-initiating cells induces chemotherapeutic resistance via Bmi-1 and ABCC5. Clin Cancer Res. 2011;17 (22):7105-15.
55. Dong XY, Guo P, Boyd J, Sun X, Li Q, Zhou W, et al. Implication of snoRNA U50 in human breast cancer. J Genet Genomics. 2009;36(8):447-54.
56. Girard A, Sachidanandam R, Hannon GJ, Carmell MA. A germline-specific class of small RNAs binds mammalian Piwi proteins. Nature. 2006;442(7099):199- 202. (Pubitemid 44086566)
57. Lu Y, Li C, Zhang K, Sun H, Tao D, Liu Y, et al. Identification of piRNAs in Hela cells by massive parallel sequencing. BMB Rep. 2010;43(9):635-41.
58. Lee EJ, Banerjee S, Zhou H, Jammalamadaka A, ArcilaM, Manjunath BS, et al. Identification of piRNAs in the central nervous system. RNA. 2011;17(6):1090-9.
59. Lee JH, Jung C, Javadian-Elyaderani P, Schweyer S, Schutte D, Shoukier M, et al. Pathways of proliferation and antiapoptosis driven in breast cancer stem cells by stem cell protein piwil2. Cancer Res. 2010;70(11):4569-79.
60. Farazi TA, Horlings HM, Ten Hoeve JJ, Mihailovic A, Halfwerk H, Morozov P, et al. MicroRNA sequence and expression analysis in breast tumors by deep sequencing. Cancer Res. 2011;71(13):4443-53.
61. Kim SJ, Oh JS, Shin JY, Lee KD, Sung KW, Nam SJ, et al. Development of microRNA-145 for therapeutic application in breast cancer. J Control Release. 2011;155(3):427-34.
62. Trang P, Medina PP,Wiggins JF, Ruffino L, Kelnar K, Omotola M, et al. Regression of murine lung tumors by the let-7 microRNA. Oncogene. 2010;29(11):1580-7.
63. Wiggins JF, Ruffino L, Kelnar K, Omotola M, Patrawala L, Brown D, et al. Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res. 2010;70(14):5923-30.
64. Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell. 2009;137 (6):1005-17.
65. Rask L, Balslev E, Jorgensen S, Eriksen J, Flyger H, Moller S, et al. High expression of miR-21 in tumor stroma correlates with increased cancer cell proliferation in human breast cancer. APMIS. 2011;119(10):663-73.
66. Asaga S, Kuo C, Nguyen T, Terpenning M, Giuliano AE, Hoon DS. Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. Clin Chem. 2011;57(1):84-91.